ANXA1 and metabolic dysfunction-associated steatohepatitis: Recently we demonstrated that endogenous anxA1 contributes to resolution of chronic inflammation in a mouse model of nonalcoholic steatohepatitis (NASH) through stimulation of IL-10 production and down-modulation of M1 polarization [36].